Arkolith/Insider Trading/AVTX/Form 4

Chan Mitchell

DirectorAvalo Therapeutics, Inc. (AVTX) · full profile →Form 4 · filed May 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$72K
Net Open-Market Flow
-$72K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 6, 2026Sell(S)3K$22.88$72K3K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001789335-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML